Salsalate cuts blood sugar levels in obese adults

Simple item page
dc.contributor.authorKerr, Martha
dc.date.accessioned2019-08-14T15:00:58Z
dc.date.available2019-08-14T15:00:58Z
dc.date.issued2008
dc.description.abstractA drug approved for the treatment of arthritis may have a role in reducing the risk of diabetes and heart trouble developing in young obese individuals, Harvard researchers report. Compared with an inactive placebo, the anti-inflammatory drug salsalate reduced glucose levels by an average of 13 percent in 20 non-diabetic adults no older than 30 years of age with a body mass index (BMI) of at least 30 (classified as obese).
dc.description.urihttps://in.reuters.com/article/us-salsalate/salsalate-cuts-blood-sugar-levels-in-obese-adults-idINKUA56401020080215
dc.identifierhttps://doi.org/10.13016/wbgz-x6r9
dc.identifier.citationKerr, Martha (2008) Salsalate cuts blood sugar levels in obese adults. UNSPECIFIED.
dc.identifier.otherEprint ID 929
dc.identifier.urihttp://hdl.handle.net/1903/22888
dc.subjectPharmacotherapy
dc.subjectDiabetes
dc.subjectObesity
dc.subjectobese individuals
dc.subjectdiabetes
dc.subjectheart trouble
dc.subjectsalsalate
dc.subjectglucose levels
dc.subjectinsulin sensitivity
dc.subjectinflammatory cardiovascular risk
dc.subjectobesity
dc.subjectarthritis
dc.titleSalsalate cuts blood sugar levels in obese adults
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Salsalate_cuts_blood_sugar_levels_in_obese_adults.pdf
Size:
16.35 KB
Format:
Adobe Portable Document Format
Download

Collections

Minority Health and Health Equity Archive